Immunization of HLA-A0201 and/or HLA-DPbeta104 patients with metastatic melanoma using epitopes from the NY-ESO-1 antigen (Q36430745)

14 August 2017

Immunization of HLA-A*0201 and/or HLA-DPbeta1*04 patients with metastatic melanoma using epitopes from the NY-ESO-1 antigen (English)

1 reference

14 August 2017

0 references

1 reference

7

Steven A Rosenberg

1 reference

14 August 2017

3

Suzanne L Topalian

1 reference

14 August 2017

Hung T Khong

1

1 reference

14 August 2017

James C Yang

2

1 reference

14 August 2017

Richard M Sherry

4

1 reference

14 August 2017

Sharon A Mavroukakis

5

1 reference

14 August 2017

Donald E White

6

1 reference

14 August 2017

1 November 2004

1 reference

14 August 2017

Journal of Immunotherapy

1 reference

14 August 2017

27

1 reference

14 August 2017

6

1 reference

14 August 2017

472-477

1 reference

Immunization of patients with metastatic melanoma using both class I- and class II-restricted peptides from melanoma-associated antigens

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2227905

Multiepitope CD8(+) T cell response to a NY-ESO-1 peptide vaccine results in imprecise tumor targeting

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2227905

Pre-existing immunity to tyrosinase-related protein (TRP)-2, a new TRP-2 isoform, and the NY-ESO-1 melanoma antigen in a patient with a dramatic response to immunotherapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2227905

CD4(+) T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: association with NY-ESO-1 antibody production

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2227905

A new era for cancer immunotherapy based on the genes that encode cancer antigens

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2227905

The central role of CD4(+) T cells in the antitumor immune response

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2227905

A survey of the humoral immune response of cancer patients to a panel of human tumor antigens

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2227905

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2227905

Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2227905

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2227905

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2227905

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2227905

Monophasic and biphasic synovial sarcomas abundantly express cancer/testis antigen NY-ESO-1 but not MAGE-A1 or CT7

21 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15534491

12 December 2020

inferred from PubMed ID database lookup

Induction of tumor-reactive cytotoxic T-lymphocytes using a peptide from NY-ESO-1 modified at the carboxy-terminus to enhance HLA-A2.1 binding affinity and stability in solution

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15534491

12 December 2020

inferred from PubMed ID database lookup

The role of CD4+ T cell responses in antitumor immunity

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15534491

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1097/00002371-200411000-00007

1 reference

release_bzcmhxxywbgyrbdzndkybir2z4

14 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bzcmhxxywbgyrbdzndkybir2z4

24 November 2022

mapped directly with Wikidata item

1 reference

14 August 2017

1 reference